Geschatte realtime
Cboe BZX
21:44:04 02-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
51,5
USD
|
+2,07%
|
|
+5,45%
|
+48,14%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
1.021
|
1.011
|
1.609
|
1.080
|
2.361
|
3.728
|
-
|
Bedrijfswaarde
1 |
1.021
|
1.011
|
1.609
|
1.080
|
2.361
|
3.728
|
3.728
|
K/w-verhouding
|
70
x
|
-67,5
x
|
65,5
x
|
111
x
|
695
x
|
97
x
|
66,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
0,88
x
|
0,94
x
|
1,22
x
|
0,76
x
|
1,46
x
|
2,12
x
|
1,97
x
|
Bedrijfswaarde/omzet
|
0,88
x
|
0,94
x
|
1,22
x
|
0,76
x
|
1,46
x
|
2,12
x
|
1,97
x
|
Bedrijfswaarde/EBITDA
|
6,22
x
|
7,25
x
|
7,35
x
|
5,61
x
|
10,2
x
|
13,9
x
|
12,5
x
|
Bedrijfswaarde/FCF
|
33,8
x
|
7,24
x
|
139
x
|
40,1
x
|
53,3
x
|
48,5
x
|
40
x
|
FCF Yield
|
2,96%
|
13,8%
|
0,72%
|
2,5%
|
1,87%
|
2,06%
|
2,5%
|
Price to Book
|
6,73
x
|
6,1
x
|
7,04
x
|
3,26
x
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
50.272
|
51.636
|
53.437
|
57.361
|
67.895
|
73.896
|
-
|
Referentieprijs
2 |
20,30
|
19,57
|
30,11
|
18,83
|
34,77
|
50,45
|
50,45
|
Datum van publicatie
|
12/03/20
|
8/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
1.154
|
1.072
|
1.315
|
1.430
|
1.617
|
1.755
|
1.894
|
EBITDA
1 |
164,1
|
139,5
|
218,9
|
192,5
|
232,3
|
268,6
|
298,9
|
Bedrijfsresultaat (EBIT)
1 |
69,88
|
35,68
|
82,55
|
46,36
|
98,7
|
121,7
|
144,1
|
Operationele Marge
|
6,05%
|
3,33%
|
6,28%
|
3,24%
|
6,11%
|
6,94%
|
7,61%
|
Resultaat voor belastingen (EBT)
1 |
29,67
|
-0,854
|
58,88
|
42,97
|
38,81
|
85,45
|
110,6
|
Nettowinst (verlies)
1 |
14,76
|
-14,84
|
24,73
|
10,65
|
3,044
|
38,7
|
56,72
|
Nettomarge
|
1,28%
|
-1,38%
|
1,88%
|
0,74%
|
0,19%
|
2,2%
|
3%
|
WPA
2 |
0,2900
|
-0,2900
|
0,4600
|
0,1700
|
0,0500
|
0,5200
|
0,7600
|
Free Cash Flow
1 |
30,17
|
139,6
|
11,62
|
26,97
|
44,26
|
76,89
|
93,27
|
FCF-marge
|
2,61%
|
13,02%
|
0,88%
|
1,89%
|
2,74%
|
4,38%
|
4,93%
|
Kasstroomconversie (ebitda)
|
18,38%
|
100,09%
|
5,31%
|
14,01%
|
19,05%
|
28,63%
|
31,2%
|
Kasstroomconversie (nettowinst)
|
204,45%
|
-
|
46,98%
|
253,2%
|
1.454,11%
|
198,7%
|
164,43%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/03/20
|
8/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
332,7
|
333,2
|
341,8
|
354,4
|
350
|
383,9
|
390,6
|
403,7
|
402
|
420,4
|
421,7
|
438,5
|
434,2
|
460,5
|
459
|
EBITDA
1 |
62,28
|
54,51
|
38,13
|
51,34
|
45,77
|
57,23
|
48,16
|
60,44
|
57,92
|
65,81
|
55,29
|
68,66
|
68,19
|
76,43
|
64,5
|
Bedrijfsresultaat (EBIT)
1 |
32,57
|
4,652
|
-1,719
|
19,56
|
6,924
|
21,6
|
6,671
|
24,44
|
43,25
|
24,34
|
14,29
|
34,71
|
33,25
|
39,48
|
17,87
|
Operationele Marge
|
9,79%
|
1,4%
|
-0,5%
|
5,52%
|
1,98%
|
5,63%
|
1,71%
|
6,05%
|
10,76%
|
5,79%
|
3,39%
|
7,92%
|
7,66%
|
8,57%
|
3,89%
|
Resultaat voor belastingen (EBT)
1 |
26,43
|
3,34
|
9,859
|
17,23
|
8,635
|
7,243
|
-13,15
|
13,94
|
31,29
|
6,73
|
3,692
|
27,71
|
24,58
|
29,47
|
11,38
|
Nettowinst (verlies)
1 |
16,22
|
-3,823
|
3,013
|
7,905
|
0,668
|
-0,934
|
-21
|
8,369
|
17,54
|
-1,858
|
-3,744
|
14,47
|
12,24
|
15,74
|
1,772
|
Nettomarge
|
4,88%
|
-1,15%
|
0,88%
|
2,23%
|
0,19%
|
-0,24%
|
-5,38%
|
2,07%
|
4,36%
|
-0,44%
|
-0,89%
|
3,3%
|
2,82%
|
3,42%
|
0,39%
|
WPA
2 |
0,3000
|
-0,0700
|
0,0500
|
0,1300
|
0,0100
|
-0,0200
|
-0,3600
|
0,1200
|
0,2500
|
-0,0300
|
-0,0550
|
0,1950
|
0,1650
|
0,2100
|
0,0250
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
8/11/21
|
1/03/22
|
9/05/22
|
9/08/22
|
9/11/22
|
1/03/23
|
9/05/23
|
8/08/23
|
8/11/23
|
29/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
30,2
|
140
|
11,6
|
27
|
44,3
|
76,9
|
93,3
|
ROE (netto-inkomsten/eigen vermogen)
|
10,6%
|
-
|
12,5%
|
4,28%
|
-
|
4,1%
|
5,7%
|
ROA (netto-inkomsten/totale activa)
|
1,07%
|
-
|
1,29%
|
0,54%
|
-
|
1,5%
|
2,2%
|
Totale activa
1 |
1.377
|
-
|
1.923
|
1.989
|
-
|
2.580
|
2.578
|
Nettoactief per aandeel
|
3,010
|
3,210
|
4,270
|
5,770
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
73
|
93,3
|
138
|
119
|
177
|
136
|
155
|
Capex/omzet
|
6,32%
|
8,71%
|
10,48%
|
8,35%
|
10,92%
|
7,76%
|
8,17%
|
Datum van publicatie
|
12/03/20
|
8/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
-
|
-
|
Laatste slotkoers
50,45
USD Gemiddelde koersdoel
53,33
USD Spread / Gemiddelde doel +5,72% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +48,14% | 3,73 mld. | | -19,14% | 8,22 mld. | | -8,06% | 2,46 mld. | | -38,71% | 2,46 mld. | | -8,84% | 2,36 mld. | | -11,06% | 1,78 mld. | | -19,07% | 1,52 mld. | | -40,78% | 1,21 mld. | | +8,32% | 1,12 mld. | | -12,27% | 1,09 mld. |
Medische en diagnostische laboratoria
|